Our Summary

This study investigated a method of treating symptomatic subserosal uterine myomas, which are non-cancerous growths on the uterus. The researchers used a technique called ultrasound-guided percutaneous microwave ablation, which involves using ultrasound to precisely guide a needle into the growth, then using microwave energy to destroy it.

The researchers treated 69 patients with this method, and monitored them for up to a year afterward. They found that the volume of the myomas decreased significantly over time, and that patients’ symptoms improved. There were no serious injuries or complications from the treatment.

The researchers conclude that this method of treatment is promising, but they recommend more studies with larger groups of patients to confirm their results.

FAQs

  1. What method did the study use to treat symptomatic subserosal uterine myomas?
  2. What were the results of this study on the use of ultrasound-guided percutaneous microwave ablation for treating uterine myomas?
  3. What do the researchers recommend for future studies on this method of treatment?

Doctor’s Tip

A doctor might tell a patient considering uterine ablation that it is a minimally invasive procedure that can help improve symptoms such as heavy menstrual bleeding or pelvic pain. They may advise the patient to discuss their specific concerns and goals with their healthcare provider to determine if uterine ablation is the right option for them. Additionally, the doctor may recommend that the patient follow post-procedure instructions carefully to ensure the best possible outcome.

Suitable For

Patients who are typically recommended for uterine ablation are those with symptomatic subserosal uterine myomas, also known as fibroids. These patients may experience symptoms such as heavy menstrual bleeding, pelvic pain, and pressure or bloating in the abdomen. Uterine ablation may be recommended for those who have not responded to other forms of treatment, such as medication or hormonal therapy, or for those who wish to avoid more invasive surgical procedures like a hysterectomy. It is important for patients considering uterine ablation to discuss their options with a healthcare provider to determine if this treatment is appropriate for their individual situation.

Timeline

Before uterine ablation:

  • Patient experiences symptoms related to uterine myomas, such as heavy menstrual bleeding, pelvic pain, and pressure
  • Patient undergoes diagnostic tests such as ultrasound or MRI to confirm the presence of uterine myomas
  • Patient discusses treatment options with their healthcare provider and decides to undergo uterine ablation

After uterine ablation:

  • Patient undergoes ultrasound-guided percutaneous microwave ablation procedure
  • Patient may experience mild discomfort or cramping after the procedure
  • Over the following weeks and months, the volume of the myomas decreases and symptoms improve
  • Patient follows up with their healthcare provider for monitoring and evaluation of treatment success
  • Patient experiences long-term relief from symptoms and improved quality of life

What to Ask Your Doctor

Some questions a patient should ask their doctor about uterine ablation include:

  1. What is uterine ablation and how does it work?
  2. Am I a suitable candidate for uterine ablation?
  3. What are the potential risks and complications associated with uterine ablation?
  4. How effective is uterine ablation in treating my condition?
  5. What can I expect during and after the procedure?
  6. What is the recovery process like after uterine ablation?
  7. Are there any long-term effects or implications of undergoing uterine ablation?
  8. Are there any alternative treatment options available for my condition?
  9. How often will I need follow-up appointments after uterine ablation?
  10. Can you provide me with more information or resources about uterine ablation?

Reference

Authors: Yang Y, Hao Y, Zhang J, Han Z, Yu J, Liu F, Ma X, Xu R. Journal: J Minim Invasive Gynecol. 2019 Mar-Apr;26(3):544-550. doi: 10.1016/j.jmig.2018.06.014. Epub 2018 Jun 28. PMID: 29964178